2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: optimization of human microsomal stability

Bioorg Med Chem Lett. 2010 Apr 15;20(8):2648-53. doi: 10.1016/j.bmcl.2010.02.031. Epub 2010 Feb 11.

Abstract

Isosteric replacement of one of the 3,5-ethylene-bridged morpholines in 2-arylureidophenyl-4,6-di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines led to significant improvements in human microsomal stability. 3-R-Me-morpholine and tetrahydropyran were identified as preferred isosteres for the bridged morpholine. Combination of tetrahydropyran substitution with an N-Me-piperazinophenylureido group led to 27, that selectively suppressed mTOR biomarkers in vivo and possessed excellent efficacy in a murine xenograft model.

MeSH terms

  • Animals
  • Humans
  • Inhibitory Concentration 50
  • Mice
  • Microsomes / drug effects*
  • Microsomes / metabolism
  • Transplantation, Heterologous
  • Triazines / chemistry
  • Triazines / pharmacology*

Substances

  • Triazines